Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Look for Pharma Talent with Fleming Europe

Published: Monday, February 27, 2012
Last Updated: Monday, February 27, 2012
Bookmark and Share
Are you looking for a way to find and retain talented individuals for your company?

Staying competitive in the pharmaceutical industry requires the ability to bridge gaps between multi-disciplinary areas such as science, business, law and public relations. The most successful pharma and biotech companies know that behind the success is a pool of talented personnel that are able to think outside the box and adapt to an ever-evolving environment.  

Fleming Europe has organized the Talent Forward 2012, its 7th edition of the successful Pharma HR series. The event will take place in the comfort of the Hotel Rey Juan Carlos I, in Barcelona on 3 – 4 May 2012.

The Masterclass session, “Aligning organizational coaching to talent management strategy,” will be the center of attention. Facilitated by Dr. Paul Turner, Honorary research fellow from Birmingham city university, UK, will concentrate on talent challenges in the pharma industry, various dimensions of talent management, and coaching & relationship management capability.

The Talent forward 2012 survey, currently available online, will conclude the afternoon session. The evaluation and results advices will be presented and discussed.

The 2-day conference will be rich in topics and will cover all the stages in the pharma talent life-cycle – innovative pharma HR talent acquisition, finding talent for special positions, developments in talent mapping, examples of the most effective talent development programs, clever talent retention and reengagement and the influence of popular social media.

Panel discussions enabling the interaction with prominent speakers from Pfizer, Sanofi Aventis, GlaxoSmithKline, Eli Lilly, Abbott, Amgen, Sandoz, Nycomed, Merck, Shire, etc. are scheduled throughout the conference.

The pharmaceutical industry of developed economies is already saturated with a dedicated workforce. In emerging markets pharma companies have to fight for qualified personnel. How to “capture & hire” is only the first step to take. How to retain such talent is the vital question these companies need to answer.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Activating Cancer-Killing Immune Cells
A UCL research team have discovered that cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy cancer.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!